All blog posts
Total 231 results for
Showing 12 out of 231 results
27 avril 2026
The EU Pharma Package is finally here – here's the settled position on key areas
01 avril 2026
IP Australia releases consultation paper on IP reforms
12 mars 2026
Snapshot: Key European pharma regulatory, IP and competition developments from 2025 for the pharmaceutical sector
15 décembre 2025
A new era for EU pharmaceutical law: political agreement reached on the reform
09 décembre 2025
Preserving the status quo: Boehringer Ingelheim awarded interim injunction
03 septembre 2025
Herbert Smith Freehills Kramer comments for LSIPR on small molecule litigation in the UPC
31 juillet 2025
EU Regulatory Reform for Medicinal Products: Bolar exemption
30 juillet 2025
When will modifying a chemical scaffold be inventive? The UK Court of Appeal opines in the Xtandi case
13 mai 2025
EU Regulatory Reform for Medicinal Products: Changes to MAs, supply, and transparency
30 avril 2025
EU Regulatory Reform for Medicinal Products: Review of new regulatory exclusivities
25 février 2025
CJEU clears the way for single courts determining infringement actions in multiple jurisdictions without invalidity counterclaims interfering with the process (BSH Hausgerate v Electrolux)
10 février 2025
Key Takeaways from the UPC Litigation Forum and Pharma & Biotech Patent Litigation Europe Summit 2025
Showing 12 out of 231 results
View moreKey contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
Peng Lei
Partner, Kewei, Mainland China and Shanghai
Alexandra Neri
Partner, Paris
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London